ALL
From the Journals
Genetic shift increases susceptibility to childhood ALL
From the Journals
New treatments have transformed Ph+ acute lymphoblastic leukemia care
From the Journals
Better CNS control in children with ALL: ‘Goldilocks’ approach
News
FDA approves new asparaginase product for leukemia
The problem is that about 20% of patients become allergic to the standard option, asparaginase derived from Escherichia coli.
Conference Coverage
Ponatinib/blinatumomab start strong against Ph+ALL
Conference Coverage
CAR T cells rescue younger children with relapsed/refractory ALL
Children younger than 3 years with relapsed/refractory acute lymphoblastic leukemia had CAR T therapy outcomes similar to those of older children...
Conference Coverage
Venetoclax shows activity against T-ALL in children
Conference Coverage
Sex differences in pediatric B-ALL outcomes persist
Conference Coverage
Pediatric cancer survivors at risk for opioid misuse
Conference Coverage
High MRD rates with CAR T in r/r B-ALL in kids
Of 24 patients with relapsed/refractory disease, 16 went on to allogeneic stem cell transplant after responding to therapy with KTE-X19.
From the Journals
Low-calorie diet linked to improved chemo response in leukemia